PCM
AGN

Penserra Capital Management’s Allergan plc AGN Stock Holding History

Penserra Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-1,071
Closed -$179K – 996
2019
Q2 		$179K Buy
+1,071
New +$148K 0.01% 414
2018
Q4 		– Sell
-1,564
Closed -$297K – 825
2018
Q3 		$297K Buy
1,564
+221
+16% +$40.6K 0.02% 380
2018
Q2 		$223K Buy
1,343
+355
+36% +$57K 0.01% 304
2018
Q1 		$166K Buy
988
+78
+9% +$13.1K 0.02% 264
2017
Q4 		$148K Buy
910
+143
+19% +$25.7K 0.02% 236
2017
Q3 		$161K Buy
767
+91
+13% +$21.2K 0.04% 224
2017
Q2 		$164K Buy
+676
New +$159K 0.06% 243
2017
Q1 		– Sell
-70
Closed -$14K – 903
2016
Q4 		$14K Buy
70
+15
+27% +$3.11K ﹤0.01% 738
2016
Q3 		$12K Buy
55
+22
+67% +$5.38K ﹤0.01% 784
2016
Q2 		$8K Sell
33
-109
-77% -$25.1K ﹤0.01% 814
2016
Q1 		$37K Buy
142
+38
+37% +$10.9K ﹤0.01% 341
2015
Q4 		$33K Buy
+104
New +$31K ﹤0.01% 308

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $6.16B AUM 3.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Penserra Capital Management's AGN Position: Q3 2019 in Review

Penserra Capital Management sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 1,071 shares — an estimated $179K sold.

Penserra Capital Management first reported a position in AGN in Q4 2015 and held it in 12 quarters. The position peaked at $297K in Q3 2018. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • Penserra Capital Management reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • Penserra Capital Management sold 1,071 Allergan plc shares in Q3 2019, an estimated $179K.
  • Penserra Capital Management first reported a position in Allergan plc in Q4 2015 and held it in 12 quarters.
  • Penserra Capital Management's Allergan plc position peaked at $297K in Q3 2018.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on Penserra Capital Management's 13F filing for Q3 2019, filed 15 Nov 2019.